Effective ribavirin concentration in mice brain using cyclodextrin as a drug carrier: Evaluation in a measles encephalitis model

Antiviral Research

Volumn 81, Issue 3, 2009, Pages 261-266

  Jeulin, H ^a   Venard, V ^a   Carapito, D ^a   Finance, C ^a   Kedzierewicz, F ^a  

^a NANCY UNIVERSITÉ   (France)

Author keywords

Alpha cyclodextrin; Blood brain barrier; Encephalitis; Measles virus; Ribavirin

Indexed keywords

ALPHA CYCLODEXTRIN; RIBAVIRIN;

ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEASLES VIRUS; MOUSE; MULTIPLE DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; VIRUS ENCEPHALITIS;

ANIMALS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DRUG CARRIERS; ENCEPHALITIS, VIRAL; FEMALE; MALE; MEASLES; MICE; RIBAVIRIN; TIME FACTORS;

MEASLES VIRUS; MUS;

EID: 60249084015     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.12.006     Document Type: Article

References (28)

1. Avison M.J., Nath A., Greene-Avison R., Schmitt F.A., Greenberg R.N., and Berger J.R. Neuroimaging correlates of HIV-associated BBB compromise. J. Neuroimmunol. 157 (2004) 140-146
2. Bussereau F., Picard M., Blancou J., and Sureau P. Treatment of rabies in mice and foxes with antiviral compounds. Acta Virol. 32 (1988) 33-49
3. Canonico P.G., Kende M., Luscri B.J., and Huggins J.W. In-vivo activity of antivirals against exotic RNA viral infections. J. Antimicrob. Chemother. 14 Suppl. A (1984) 27-41
4. Crance J.M., Scaramozzino N., Jouan A., and Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 58 (2003) 73-79
5. Day C.W., Smee D.F., Julander J.G., Yamshchikov V.F., Sidwell R.W., and Morrey J.D. Error-prone replication of West Nile virus caused by ribavirin. Antiviral Res. 67 (2005) 38-45
6. Ferrara E.A., Oishi J.S., Wannemacher Jr. R.W., and Stephen E.L. Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys. Antimicrob. Agents Chemother. 19 (1981) 1042-1049
7. Gilbert B.E., and Wyde P.R. Pharmacokinetics of ribavirin aerosol in mice. Antimicrob. Agents Chemother. 32 (1988) 117-121
8. Gilbert B.E., Wyde P.R., Wilson S.Z., and Robins R.K. Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus. Antimicrob. Agents Chemother. 35 (1991) 1448-1453
9. Grancher N., Kedzierewicz F., Venard V., Marsura A., Finance C., and Le Faou A. Physicochemical Study of Ribavirin Complexes with alpha-, beta- and gamma-cyclodextrins. J. Incl. Phenom. Macroc. Chem. 51 (2005) 149-157
10. Grancher N., Venard V., Kedzierewicz F., Ammerlaan W., Finance C., Muller C.P., and Le Faou A. Improved antiviral activity in vitro of ribavirin against measles virus after complexation with cyclodextrins. Antiviral Res. 62 (2004) 135-137
11. Homma M., Jayewardene A.L., Gambertoglio J., and Aweeka F. High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes. Antimicrob. Agents Chemother. 43 (1999) 2716-2719
12. Honda Y., Hosoya M., Ishii T., Shigeta S., and Suzuki H. Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters. Antimicrob. Agents Chemother. 38 (1994) 653-655
13. Hosoya M., Mori S., Tomoda A., Mori K., Sawaishi Y., Kimura H., Shigeta S., and Suzuki H. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrob. Agents Chemother. 48 (2004) 4631-4635
14. Huffman J.H., Sidwell R.W., Khare G.P., Witkowski J.T., Allen L.B., and Robins R.K. In vitro effect of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob. Agents Chemother. 3 (1973) 235-241
15. Jeulin H., Grancher N., Kedzierewicz F., Finance C., Le Faou A.E., and Venard V. In vivo antiviral activity of ribavirin/alpha-cyclodextrin complex: evaluation on experimental measles virus encephalitis in mice. Int. J. Pharm. 357 (2008) 148-153
16. Jeulin H., Grancher N., Kedzierewicz F., Le Faou A.E., and Venard V. Evaluation by Q-RTPCR of the efficacy of ribavirin complexed with beta-cyclodextrin against measles virus in a mouse encephalitis model. Pathol. Biol. (Paris) 54 (2006) 541-544
17. Loftsson T., and Brewster M.E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85 (1996) 1017-1025
18. Loftsson T., and Duchêne D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329 (2007) 1-11
19. Loftsson T., Vogensen S.B., Brewster M.E., and Konrádsdóttir F. Effects of cyclodextrins on drug delivery through biological membranes. J. Pharm. Sci. 96 (2007) 2532-2546
20. Monnaert V., Betbeder D., Fenart L., Bricout H., Lenfant A.M., Landry C., Cecchelli R., Monflier E., and Tilloy S. Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier. J. Pharmacol. Exp. Ther. 311 (2004) 1115-1120
21. Monnaert V., Tilloy S., Bricout H., Fenart L., Cecchelli R., and Monflier E. Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier. J. Pharmacol. Exp. Ther. 310 (2004) 745-751
22. Persidsky Y., Ramirez S.H., Haorah J., and Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 1 (2006) 223-236
23. Sidwell R.W., Allen L.B., Khare G.P., Huffman J.H., Witkowski J.T., Simon L.N., and Robins R.K. Effect of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. Antimicrob. Agents Chemother. 3 (1973) 242-246
24. Stoll M.S., and Hounsell E.F. Selective purification of reduced oligosaccharides using a phenylboronic acid bond elut column: potential application in HPLC, mass spectrometry, reductive amination procedures and antigenic/serum analysis. Biomed. Chromatogr. 2 (1988) 249-253
25. Tilloy S., Monnaert V., Fenart L., Bricout H., Cecchelli R., and Monflier E. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier. Bioorg. Med. Chem. Lett. 16 (2006) 2154-2157
26. Uekama K., and Otagiri M. Cyclodextrins in drug carrier systems. Crit. Rev. Ther. Drug Carrier Syst. 3 (1987) 1-40
27. Wyde P.R., Moore-Poveda D.K., De Clercq E., Neyts J., Matsuda A., Minakawa N., Guzman E., and Gilbert B.E. Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections. Antimicrob. Agents Chemother. 44 (2000) 1146-1152
28. Wyshak G., and Detre K. Estimating the number of organisms in quantal assays. Appl. Microbiol. 23 (1972) 784-790